The Impact of ICH E6(R3) on U.S. and Canadian IRBs
Now that FDA has published the ICH E6(R3) Good Clinical Practice (GCP) guidance, aligning...
FEATURED E-BOOK
Making Good Clinical Practice More Understandable
This eBook dives into GCP’s role in the clinical research ecosystem and how it protects participant rights, safety, and confidentiality.
Medicare Coverage Analysis Worksheet
Medicare Coverage Analysis outlines criteria to determine coverage eligibility, guiding trials through compliance with...
Advarra’s Perspective on FDA’s Draft AI Guidance: Advancing Responsible Innovation
Estimated reading time: 4 minutes The U.S. Food and Drug Administration’s (FDA’s) recent draft...
The Story Behind Braid: How the Brand Reflects Advarra’s Vision for Data and AI in Clinical Research
Estimated reading time: 6 minutes Advarra partnered with PreHealth, a brand growth and experience...
Are you prepared for ICH E6 (R3)?
The third revision (R3) of the ICH E6 Guideline for Good Clinical Practice represents...
The Executive Order that Brings Private Bioresearch Under Federal Oversight
The release of ICH E6(R3) in January 2025 marks the most significant evolution in...
ICH E6(R3) Implementation Starts Now: Are You Ready?
The release of ICH E6(R3) in January 2025 marks the most significant evolution in...
Q&A with Advarra’s new Senior Vice President, FDA Regulatory Advisor, Jan Hewett
Clinical research drives medical progress. Advarra ensures participant safety and ethical standards through expert...
The Value of Clinical Research
Clinical research drives medical progress. Advarra ensures participant safety and ethical standards through expert...
Looking for More?
To register for upcoming webinars and see where we’ll be next, go to the Events page.
Want to see the latest news and updates about Advarra? You can find them in the Newsroom.
